Po­laris cash­es in its chips as Langer-backed Ar­sia is auc­tioned off to Ea­gle for up to $78M

Re­cent­ly frus­trat­ed in its at­tempt to win a reg­u­la­to­ry ap­proval at the FDA, Ea­gle Phar­ma­ceu­ti­cals $EGRX has swooped in to buy Po­laris-backed Ar­sia Ther­a­peu­tics for a rel­a­tive­ly mod­est up­front pay­ment. The deal comes with the ser­vices of Ar­sia’s sci­en­tif­ic co-founders, MIT’s high pro­file drug de­liv­ery spe­cial­ist Bob Langer and Alexan­der Klibanov, who are sign­ing on as ad­vis­ers to the new own­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER